Remove 2025 Remove Packaging Remove Pharmaceutical Companies
article thumbnail

Sustainability continues to steer pharmaceutical packaging market

European Pharmaceutical Review

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 billion by 2033, according to a study published by Towards Packaging. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market.

article thumbnail

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Pharmaceutical Technology

This rapid processing not only enhances throughput, but will also allow pharmaceutical companies to respond more swiftly to market demands. DMC’s innovative design incorporates an ultrathin conductive layer, typically made of gold, which enables the application of electrical fields across ionic and affinity membrane adsorbers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 Innovative Trends in Pharma Marketing: Strategies for Industry Success in 2025

Pharma Marketing Network

As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. From eco-friendly packaging to socially responsible campaigns, sustainability resonates with today’s consumers. Learn more about compliance tips at Pharma Marketing.

article thumbnail

FOPE & PharmaState Academy host Session 12 of the PULSE series

Express Pharma

Jayakumar gave examples of common issues, such as packaging damage or consistency problems in ointments, stressing the importance of not dismissing seemingly minor complaints, as they could escalate into more significant quality issues.

article thumbnail

Kashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue in FY26

Express Pharma

The company has set a revenue target of ₹100 crore for the financial year 2025–26, following a 100 per cent year-on-year growth from ₹20 crore in FY23–24 to ₹40 crore in FY24–25. To support this, the company is investing approximately ₹20 crore in infrastructure development, which is already underway.

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Indian pharmaceutical companies have specialised in reverse-engineering complex medicines and producing biosimilars as alternatives to costly biologics.

article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54